Spurious medicines worth Rs 6.60 crore seized in raid at Kolkata premises Written By Ruchika Sharma1 Jan 2025 4:57 PM ISTIn a joint investigation conducted by the Central Drugs Standard Control Organization (CDSCO), East Zone, and the Drugs Control Directorate, West...
Sanofi gets CDSCO Panel nod to study Antidiabetic Drug Insulin Glargine and Lixisenatide Injection Written By Dr. Divya Colin1 March 2024 6:00 PM ISTNew Delhi: The drug major Sanofi has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Lupin Launches Dapaturn GM Range for Improved Approach to Manage Type 2 Diabetes Written By Dr. Nandita Mohan1 Jan 2024 11:45 AM ISTGlobal pharma major Lupin Limited announced the launch of Dapaturn GM Forte for the treatment of diabetic patients in India. Lupin's Dapaturn GMâ„¢...
Medical Bulletin 06/October/2023 Isra Zaman6 Oct 2023 3:00 PM ISTHere are the top medical news of the day:Male pattern baldness linked to skin cancer risk: New research findings Balding men may face a higher risk...
How Vildagliptin Improves Time in Range in T2DM patients ft-Prof. Dr Aravinda Jagadeesha Written By Dr. Nandita Mohan10 Jan 2023 11:00 AM IST The increased alpha and beta cell sensitivity to glucose by DPP4 inhibitors modulate not only chronic hyperglycemia but also daily glucose...
Tzield, the World's First USFDA approved drug to delay type 1 diabetes onset to cost more than Rs 11 lakh per vial, confirm makers Ruchika Sharma19 Nov 2022 11:49 AM ISTNew Jersey: With the recent USFDA, approval of the first drug to delay type 1 diabetes onset, teplizumab, makers of the drug Provention Bio...
Tirzepatide achieves blood sugar control and weight-loss goals faster than existing diabetes drugs Written By Dr. Kamal Kant Kohli16 Sept 2022 8:00 PM ISTTirzepatide lowers blood sugar and supports weight loss better than other drugs for type 2 diabetes (T2D) was established by in phase 3 SURPASS trials...
Common diabetes drug effective against early-stage breast cancer? Written By Dr. Nandita Mohan27 May 2022 9:00 AM ISTAccording to new findings, a widely used and inexpensive Type 2 diabetes drug, once hoped to hold enormous promise in treating breast cancer, does not...
Anticoagulants and Antidiabetics leading drugs for medication-related ER visits: JAMA Written By Dr. Shravani Dali29 Oct 2021 9:45 AM ISTTaking blood-thinners and diabetes drugs at higher-than-recommended doses or in error often leads to health complications that bring older adults to...
NPPA caps ceiling prices of 12 anti-diabetic drugs, Details Medical Dialogues Team26 Oct 2021 5:00 PM ISTTo make it possible for every Indian to afford medical treatment against diseases like diabetes, NPPA has initiated a successful step by fixing the...
Dr Reddys, MSN Labs launch of generic Empagliflozin may lead to court battle Farhat Nasim20 Oct 2021 2:01 PM ISTHyderabad: Taking head-on collision with Boehringer Ingelheim over blockbuster diabetes drug, two Indian pharma giants have recently launched their...
After selling Humalog, Trulicity rights to Cipla, Eli Lilly sacks 120 staff in India: Report Medical Dialogues Team11 Oct 2021 5:46 PM ISTNew Delhi: After transferring the rights to sell popular anti-diabetes drugs Humalog and Trulicity to Mumbai-based Cipla, Eli Lilly, a global...
